CCL2和CCR2在唾液腺腺样囊性癌中的表达及意义

doi:10.19438/j.cjoms.2019.04.005

中国口腔颌面外科杂志 ›› 2019, Vol. 17 ›› Issue (4): 311-315.doi: 10.19438/j.cjoms.2019.04.005

CCL2和CCR2在唾液腺腺样囊性癌中的表达及意义

徐博雅^1,2, 杨子桧¹, 王珺¹, 雷德林¹, 杨新杰¹

1.军事口腔医学国家重点实验室,国家口腔疾病临床医学研究中心,陕西省口腔疾病临床医学研究中心,第四军医大学口腔医院口腔颌面外科,陕西西安 710032;
2.第四军医大学基础医学院,陕西西安 710032

收稿日期:2018-10-08 修回日期:2018-11-28 出版日期:2019-07-20 发布日期:2019-08-12
通讯作者: 杨新杰,E-mail：yangxinjie@fmmu.edu.cn
作者简介:徐博雅（1996- ）,女,在读本科生,E-mail：1139004780@qq.com
基金资助:
国家自然科学基金（81302352,81372901）

Expression and clinical significance of CCL2 and CCR2 in salivary adenoid cystic carcinoma

XU Bo-ya^1,2, YANG Zi-hui¹, WANG Jun¹, LEI De-lin¹, YANG Xin-jie¹

1.State Key Laboratory of Military Stomatology and National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University. Xi'an 710032;
2.Basic Medical College, Fourth Military Medical University. Xi'an 710032, Shaanxi Province, China

Received:2018-10-08 Revised:2018-11-28 Online:2019-07-20 Published:2019-08-12

摘要/Abstract

摘要： 目的研究CCL2和CCR2在唾液腺腺样囊性癌（salivary adenoid cystic carcinoma, SACC）中的表达及其与临床病理特点之间的关系。方法采用免疫组织化学染色方法检测CCL2、CCR2在60例SACC及12例正常唾液腺组织中的表达情况,并分析其与临床病理特征之间的关系。采用 SPSS 19.0软件包对实验结果进行统计学分析。结果与正常唾液腺组织相比,CCL2和CCR2在 SACC组织中均呈现高表达,阳性表达率分别为91.7%和88.3%。CCL2和CCR2的表达与肿瘤临床分期、神经侵袭、肿瘤转移显著相关（P<0.05）;与性别、年龄、病理分型无显著相关性（P>0.05）。结论 CCL2、CCR2的表达与SACC的临床病理特征密切相关,检测两者的表达对SACC的诊断和临床病理研究具有重要的参考价值。

关键词: CCL2, CCR2, 唾液腺腺样囊性癌, 嗜神经侵袭

Abstract: PURPOSE: To investigate the expression of CCL2 and CCR2 in salivary adenoid cystic carcinoma (SACC) and to find out its correlation with clinicopathological characteristics. Methods: Immunohistochemical staining was used to detect the expression of CCL2 and CCR2 in 60 primary SACC cases and 12 normal salivary gland tissues and analyze the correlation with clinicopathological characteristics. The results and clinicopathological data were statistically analyzed by SPSS 17.0 software package with χ² test, Wilcoxon rank sum test, and Spearman's rank correlation coefficient test. Results: High expression of CCL2(91.7%) and CCR2 (88.3%) was found in SACC cases compared with normal ones. The expression of CCL2 and CCR2 was significantly associated with histopathological stages, perineural invasion and distant metastasis (P<0.05), but there was no significant correlation with age, sex, and clinical stages (P>0.05). Conclusions: The expression of CCL2 and CCR2 is closely associated with clinicopathological characteristics of SACC. Detection of the expression of CCL2 and CCR2 may have great value in the diagnosis and clinicopathlogical study.

Key words: CCL2, CCR2, Salivary adenoid cystic carcinoma, Perineural invasion

中图分类号:

R739.8

徐博雅, 杨子桧, 王珺, 雷德林, 杨新杰. CCL2和CCR2在唾液腺腺样囊性癌中的表达及意义[J]. 中国口腔颌面外科杂志, 2019, 17(4): 311-315.

XU Bo-ya, YANG Zi-hui, WANG Jun, LEI De-lin, YANG Xin-jie. Expression and clinical significance of CCL2 and CCR2 in salivary adenoid cystic carcinoma[J]. China J Oral Maxillofac Surg, 2019, 17(4): 311-315.

参考文献

[1] Li LJ, Li Y, Wen YM, et al.Clinical analysis of salivary gland tumor cases in West China in past 50 years[J]. Oral Oncol, 2008, 44(2): 187-192.
[2] Ellington CL, Goodman M, Kono SA, et al.Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data[J]. Cancer, 2012, 118(18): 4444-4451.
[3] Gondivkar SM, Gadbail AR, Chole R, et al.Adenoid cystic carcinoma: a rare clinical entity and literature review[J]. Oral Oncol, 2011, 47(4): 231-236.
[4] Liebig C, Ayala G, Wilks JA, et al.Perineural invasion in cancer: a review of the literature[J]. Cancer, 2009, 115(15): 3379-3391.
[5] Barrett AW, Speight PM.Perineural invasion in adenoid cystic carcinoma of the salivary glands: a valid prognostic indicator[J]. Oral Oncol, 2009, 45(11): 936-940.
[6] He S, Li P, Zhong Q, et al.Clinicopathologic and prognostic factors in adenoid cystic carcinoma of head and neck minor salivary glands: A clinical analysis of 130 cases[J]. Am J Otolaryngol, 2017, 38(2): 157-162.
[7] He S, He S, Chen CH, et al.The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion[J]. Mol Cancer Res, 2015, 13(2): 380-390.
[8] Kalbasi A, Komar C, Tooker GM, et al.Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma[J]. Clin Cancer Res, 2017, 23(1): 137-148.
[9] Keklikoglou I, De Palma M.Cancer: metastasis risk after anti-macrophage therapy[J]. Nature, 2014, 515(7525): 46-47.
[10] 郭春光, 刘骞, 孙力超, 等. CCL2表达与同时性结直肠癌肝转移的相关性分析[J]. 中华结直肠疾病电子杂志, 2015, 4(3): 254-259.
[11] Li X, Yao W, Yuan Y, et al.Targeting of tumor-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma[J]. Gut, 2017, 66(1): 157-167.
[12] Kowalski PJ, Paulino AF.Perineural invasion in adenoid cystic carcinoma: its causation/promotion by brain-derived neurotrophic factor[J]. Hum Pathol, 2002, 33(9): 933-936.
[13] Sanford DE, Belt BA, Panni RZ, et al.Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis[J]. Clin Cancer Res, 2013, 19(13): 3404-3415.
[14] Ding L, Li B, Zhao Y, et al.Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma[J]. Tumour Biol, 2014, 35(10): 10539-10546.
[15] Ksiazkiewicz M, Gottfried E, Kreutz M, et al.Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts[J]. Immunobiology, 2010, 215(9-10): 737-747.
[16] Zhao L, Lim SY, Gordon-Weeks AN, et al.Recruitment of a myeloid cell subset( CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis[J]. Hepatology, 2013, 57(2): 829-839.
[17] Kitamura T, Fujishita T, Loetscher P, et al.Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model[J]. Proc Natl Acad Sci USA, 2010, 107(29): 13063-13068.
[18] Amit M, Na'ara S, Gil Z. Mechanisms of cancer dissemination along nerves[J]. Nat Rev Cancer, 2016, 16(6): 399-408.
[19] Marchesi F, Piemonti L, Mantovani A, et al.Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis[J]. Cytokine Growth Factor Rev, 2010, 21(1): 77-82.

CCL2和CCR2在唾液腺腺样囊性癌中的表达及意义

Expression and clinical significance of CCL2 and CCR2 in salivary adenoid cystic carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

编辑推荐

Metrics

本文评价

[1]	李欢, 杨新杰, 王维戚, 雷德林. 应用RNA-Seq技术筛选唾液腺腺样囊性癌嗜神经侵袭相关差异表达基因[J]. 中国口腔颌面外科杂志, 2018, 16(2): 114-119.
[2]	王超, 黎婷, 严斐, 蔡文燕, 蒋星宇, 孙晋虎. 辛伐他汀联合干扰miR-21对唾液腺腺样囊性癌细胞迁移和侵袭的影响[J]. 中国口腔颌面外科杂志, 2018, 16(2): 132-137.
[3]	严斐，王超，黎婷，蔡文燕，孙晋虎，. miR-21对唾液腺腺样囊性癌细胞增殖和凋亡的影响及机制研究[J]. 中国口腔颌面外科杂志, 2017, 15(3): 209-213.
[4]	蔡文燕, 严斐, 董晶, 孙晋虎. 辛伐他汀对唾液腺腺样囊性癌细胞生长及survivin表达的影响[J]. 中国口腔颌面外科杂志, 2016, 14(3): 213-217.
[5]	单春，杨新杰，吴宝磊，王新革，雷德林. 腺样囊性癌细胞与大鼠施万细胞共培养的实验研究[J]. 中国口腔颌面外科杂志, 2015, 13(6): 481-485.
[6]	胡志强, 杨新杰, 王维玺, 贾森, 吴宝磊, 雷德林. BDNF/TrkB在唾液腺腺样囊性癌上皮-间质转化过程中的表达及意义[J]. 中国口腔颌面外科杂志, 2015, 13(3): 211-215.
[7]	何倩婷, 刘中华, 招洛丹, 赵婷婷, 王安训. miR-181a抑制唾液腺腺样囊性癌侵袭、转移机制的实验研究[J]. 中国口腔颌面外科杂志, 2015, 13(1): 11-15.